Evidence map›Paper›PMID 38003345›Full record

ArticleInternational journal of molecular sciences2023

Inactivation of Group 1B Phospholipase A

April M Haller, Patrick R Wolfkiel, Anja Jaeschke, David Y Hui

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Explainable Deep Learning of Transcriptomes Prioritizes Candidate Biomarkers With Preferential Performance in Gastric Cardia Cancer Cohorts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. The Phospholipase AJournal of lipid and atherosclerosis · 2026
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

April M HallerDepartment of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA.
Patrick R WolfkielMolecular Genetics, Biochemistry and Microbiology Graduate Program, University of Cincinnati, Cincinnati, OH 45267, USA.ORCID 0000-0001-6081-9796
Anja JaeschkeDepartment of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA.
David Y HuiDepartment of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA.ORCID 0000-0001-7333-2151
University of Cincinnati Medical Center · USUniversity of Cincinnati · US

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
Intestinal LPC/LPA modulation of gut microbiota and metabolic diseaseR01DK112657 · NIDDK · UNIVERSITY OF CINCINNATI · PI HUI, DAVID YIU-KWAN · 2016 to 2020
$1.8M
NIDDK NIH HHS P30 DK078392NIDDK NIH HHS R01 DK112657NIH HHS RO1 DK112657
6 · The paper itself

Abstract

Phospholipase A

Indexed as

ColitisColitis, UlcerativeAnimalsColonCytokinesDextran SulfateDisease Models, AnimalGroup IB Phospholipases A2Intestinal MucosaMiceMice, Inbred C57BLPhospholipases A2CytokinesDextran SulfateGroup IB Phospholipases A2Phospholipases A2inflammatory bowel diseaseintestinal stem cellsmyeloid inflammatory responsephospholipase A2

Identifiers

PMID38003345
PMCPMC10671771
OpenAlexW4388569082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.